Infective endocarditis is a relatively rare complication of TAVR, but the infection can be fatal when it does strike.

There are approximately 20,000 proteins in the human heart—and one of them, if administered as a drug, could help patients recover more quickly following a myocardial infarction.

A higher rate of cardiac arrhythmias has been observed in hospitalized COVID-19 patients, but new research suggests there’s more behind that trend than the virus itself.

Transcatheter aortic valve replacement (TAVR) with the Sapien 3 prosthesis achieved five-year clinical outcomes similar to surgical aortic valve replacement (SAVR).

A new analysis explored if age, numerous comorbidities, the use of CVD medication and Charleston Comorbidity Index scores can be used to predict mortality among confirmed COVID-19 patients. 

Approximately one in four stroke survivors are affected by disabling anxiety, but there are currently no specific guidelines in place to help these individuals. Could telemedicine be the answer? 

DiA Imaging Analysis has gained FDA clearance and CE mark approval for its AI-powered solution designed to automatically assess right ventricle dysfunction.

Overall, 86% of patients included in the study had a new injury once the intervention was complete.

Low-risk transcatheter atortic valve replacement (TAVR) patients with aortic stenosis who receive the Evolut PRO continue to experience outcomes comparable to surgery.

Protamine administration during transcatheter aortic valve replacement (TAVR) is associated with a significant reduction in life-threatening and major bleeding complications.